Target intelligence / Profile preview

Phase II detoxification enzymes inducer

01

Overview

Phase II detoxification enzymes inducer refers to any compound or agent that increases the expression or function of Phase II detoxification enzymes. These enzymes are primarily conjugating transferases that play a crucial role in drug and endogenous toxin metabolism, making these substances more water-soluble for excretion. Inducers often work through activation of cellular signaling pathways, especially the KEAP1/NRF2/ARE system, to promote synthesis of enzymes such as glutathione S-transferases, UDP-glucuronosyltransferases, and sulfotransferases. While many nutritional phytochemicals serve as natural inducers, synthetic molecules are also described in research. Induction of these enzymes is associated with enhanced cellular defense against oxidative stress, reduced toxicant/carcinogen burden, and has been explored for cancer chemoprevention and neuroprotection.

Other names
Phase II enzyme inducerPhase II detoxifying enzyme inducerPhase II enzyme activator
02

Mechanism of action

Activation of the KEAP1/NRF2/ARE pathway, leading to increased transcription of Phase II detoxification enzymes. Direct induction of enzymes such as glutathione S-transferases (GSTs), UDP-glucuronosyltransferases (UGTs), sulfotransferases, and others.

03

Biological functions

Upregulation of Phase II enzyme expressionEnhancement of xenobiotic/drug detoxification via conjugationPromotion of antioxidant defenses (when inducing enzymes with antioxidant function)
04

Disease associations

Cancer prevention (by increasing detoxification of carcinogens)Neuroprotection (by combating oxidative stress)General protection against toxicity from xenobiotics or oxidative stress
05

Safety considerations

Overactivation may disrupt normal redox homeostasisPotential carcinogenicity if induction is not balanced with Phase I enzyme activity, as some Phase II reactions can activate procarcinogens under certain circumstancesDrug interactions due to altered drug metabolism
06

Interacting drugs

Sulforaphane (from broccoli and other cruciferous vegetables)

4 more in the full profile.

07

Biomarkers

Increased levels/activity of Phase II enzymes (e.g., GST, UGT)Upregulation of NRF2 target gene expression

Beyond the preview

Go deeper on Phase II detoxification enzymes inducer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phase II detoxification enzymes inducer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call